SB

Saroj Bala

Active Director Director DIN 10040637
DIN 10040637 First appointment Feb 2023 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value •••• Premium profile

About Saroj Bala

Data last updated:

Saroj Bala is a Director at Hyrag Pharmaceuticals Private Limited (since 2023). The company operates in Food And Beverages. Hyrag Pharmaceuticals Private Limited reported revenue of ₹19.9 Lakh (FY 2022).

DIN 10040637
Primary Designation Director
Industry Food And Beverages
First Appointment 10 Feb 2023
Oldest Company Age 8 yrs
Largest company Hyrag Pharmaceuticals Private Limited · ₹19.9 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Feb 20232017₹19.9 Lakh (FY 2022)Active

Board colleagues of Saroj Bala

NameDINCompanyDesignation
Shlok Chaudhary11320416Hyrag Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hyrag Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Saroj Bala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saroj Bala

Saroj Bala currently holds 1 directorship: Hyrag Pharmaceuticals Private Limited (Director, since 10 Feb 2023, revenue ₹19.9 Lakh (FY 2022)).

Saroj Bala was first appointed on 10 Feb 2023 as Director at Hyrag Pharmaceuticals Private Limited.

The current boards of Saroj Bala's companies include Shlok Chaudhary (Hyrag Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available